Results 41 to 50 of about 1,058,319 (317)

Study of the advantages and risks of electronic retail trade in medicines

open access: yesФармацевтичний журнал, 2021
One of the most important issues of interest to scientists and practitioners of pharmacy is medicines quality assurance at all stages of their life cycle. From 2021 in Ukraine, the retail trade of medicines via the Internet was allowed.
O. O. Komarida   +4 more
doaj   +1 more source

Progressive Medicine [PDF]

open access: yesSouthern Medical Journal, 1915
n ...
openaire   +3 more sources

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker   +11 more
wiley   +1 more source

Knowledge, perception and practice of self-medication among premedical and basic science undergraduate medical students

open access: yesAsian Journal of Medical Sciences, 2016
Aims and Objective: Responsible self-medication is recognized as an important component of self-care. Medical students are in a unique position as they cannot yet legally prescribe medicines but their knowledge about and exposure to medicines increase as
P Ravi Shankar
doaj   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

Phenylpropanoids as a class of natural biologically active organo-protective compounds

open access: yesФармация и фармакология (Пятигорск)
The aim of the work was to analyze the current research state of phenylpropanoids as a special specific class of biologically active compounds and the prospects for their use for the development of medicines and biologically active food additives ...
V. A. Kurkin   +3 more
doaj   +1 more source

patterns-of-prescription-medicines-sale-through-e-marketplace-in-malaysia-and-associating-factors [PDF]

open access: bronze, 2021
Augustine Abraham Alphonsoes   +5 more
openalex   +1 more source

Of medicine and medicines

open access: yesBMJ, 2008
This week’s journal captures modern medicine’s ambivalence about modern medicines. On one hand, we look to new drugs to deliver us from illness and disease. On the other, we view the companies who deliver them with suspicion or disdain. The journal has articles to buttress both viewpoints. Firstly, drugs as salvation.
openaire   +2 more sources

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro   +11 more
wiley   +1 more source

The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study

open access: yesFrontiers in Medicine, 2022
The European Medicines Agency provides Scientific Advice to medicines developers and patient input has been an integral part of this process for many years.
Aisling Murphy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy